Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Exo Lab Italia S R L currently has 1 pending office action in its patent portfolio. This action is being reviewed by 1 distinct examiner, NOTTINGHAM, KYLE GREGORY, who is also the busiest examiner for the company. With 1 busiest examiner pending action, the entire prosecution effort is concentrated under this single individual. The outcome of the 1 pending office action will depend entirely on the specific feedback and requirements of NOTTINGHAM, KYLE GREGORY.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOTTINGHAM, KYLE GREGORY | 1 | 61.7% | +31.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18729118 | HYBRID PHARMACEUTICAL COMPOSITION OBTAINED BY CONJUGATION OF A PROTON PUMP INHIBITOR AND A CARBON ANHYDRASE INHIBITOR | NOTTINGHAM, KYLE GREGORY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18729118 | HYBRID PHARMACEUTICAL COMPOSITION OBTAINED BY CONJUGATION OF A PROTON PUMP INHIBITOR AND A CARBON ANHYDRASE INHIBITOR | NOTTINGHAM, KYLE GREGORY | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18729118 | HYBRID PHARMACEUTICAL COMPOSITION OBTAINED BY CONJUGATION OF A PROTON PUMP INHIBITOR AND A CARBON ANHYDRASE INHIBITOR | NOTTINGHAM, KYLE GREGORY | — | §101§112 | Non-Final OA | — | Pending | Jul 15, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial